Even in patients with multivessel or left main coronary artery disease, routine functional testing after PCI adds no benefit, according to a new subanalysis of the POST-PCI trial supporting the ...
After PCI, there is no value to routine functional testing above and beyond standard care in high-risk patients, new data suggest. Doing such follow-up at 1 year had no impact on 2-year clinical ...
Industry standards compliance alone cannot guarantee robust security in the face of the significant threats posed by data breaches and cyberattacks on businesses and their customers. However, by going ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among veterans who underwent post-elective PCI stress ...
BARCELONA – Routine functional testing after percutaneous cardiac interventions (PCI) did not boost clinical outcomes at 2 years in high-risk patients, according to the POST-PCI trial. The composite ...
Device-testing occurs at any of seven PCI labs located in Europe, Asia and North America. If a new device from a manufacturer fails the test, it likely could be remedied with a software fix, but if an ...
(HealthDay News) – For patients who undergo percutaneous coronary intervention (PCI), point-of-care genetic testing is feasible and identifies carriers of a CYP2C19*2 allele with high sensitivity and ...
An international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary intervention (PCI) did not meet its stated goal ...
The number of patients who undergo elective percutaneous coronary intervention (PCI) for stable coronary artery disease is increasing. However, whether many of these patients have documented ischemia ...
If you ask most folks in business IT to finish the sentence “PCI compliance is _____”, the single most unironic and demonstrative answer you’d probably get would be “hard.” A big part of why PCI is ...
PARIS — Genetic testing to determine which ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) will respond to clopidogrel, and then giving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results